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Preamble
It is becoming more apparent each day that despite a
strong national commitment to excellence in health care,
the resources and personnel are finite. It is, therefore, ap-
propriate that the medical profession examine the impact of
developing technology on the practice and cost of medical
care. Such analysis, carefully conducted, could potentially
impact on the cost of medical care without diminishing the
effectiveness of that care.
To this end, the American College of Cardiology and
the American Heart Association in 1980 established a Task
Force on Assessment of Cardiovascular Procedures with the
following charge:
The Task Force of the American College of Cardiology and
the American Heart Association shall define the role of
specific noninvasive and invasive procedures in the
diagnosis and management of cardiovascular disease.
The Task Force shall address, when appropriate, the
contribution, uniqueness, sensitivity, specificity,
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indications and contraindications and cost-effectiveness of
such specific procedures.
The Task Force shall include a Chairman and four members,
two representatives from the American Heart Association
and two representatives from the American College of
Cardiology. The Task Force may select ad hoc members
as needed upon the approval of the Presidents of both
organizations.
Recommendations of the Task Force are forwarded to the
President of each organization.
The members of the Task Force are: Roman W. De-
Sanctis, MD, Harold T. Dodge, MD, T. Joseph Reeves,
MD, Sylvan L. Weinberg, MD and Charles Fisch, MD,
Chairman.
The Subcommittee on Exercise Testing was chaired by
Robert C. Schlant, MD and included the following mem-
bers: C. Gunnar Blomqvist, MD, Robert O. Brandenburg,
MD, Robert DeBusk, MD, Myrvin H. Ellestad, MD, Gerald
F. Fletcher, MD, Victor F. Froelicher, Jr., MD, Robert J.
Hall, MD, Ben D. McCallister, MD, Paul L. McHenry,
MD, Thomas J. Ryan, MD and L. Thomas Sheffield, MD.
This document was reviewed by the officers and other
responsible individuals of the two organizations and re-
0735-1097/86/$3.50
726 SCHLANT ET AL.
SPECIAL REPORT
lACC Vol. 8. No.3
September 1986:725-38
ceived final approval in February 1986. It is being published
simultaneously in Circulation and Journal of the American
College of Cardiology. The potential impact of this docu -
ment on the practice of cardiology and some of its una-
voidable shortcomings are clearly set out in the Introduction.
Charles Fisch, MD
Indications for Exercise Testing
The American College of Cardiology/American Heart
Association Task Force on Assessment of Cardiovascular
Procedures was formed to make recommendations regarding
the appropriate use of technology in the diagnosis and treat-
ment of patients with cardiovascular disease. One such im-
portant technique is exercise testing; its potential role has
been emphasized through recent advances in the manage-
ment of patients with a variety of heart diseases. The Sub-
committee recommendations for current indications for ex-
ercise testing are consensus opinions and are based on current
data on the natural history of various cardiovascular dis-
orders and the potential value of exercise testing in an-
swering specific clinical questions. The charge to this Sub-
committee was specifically limited to standard exercise testing.
A separate task force has been charged with reviewing the
current indications for radionuclide testing, including tech-
niques using exercise.
The Subcommittee has not offered recommendations about
resources required to perform exercise testing, specific tech-
niques of exercise testing, training of individuals to perform
exercise testing or the appropriate management of patients
with positive, equivocal or negative exercise tests.
Basic to the use of any diagnostic test is the identification
of the specific clinical question that is to be asked. The most
frequent indications for performing exercise tests in patients
with known or suspected coronary artery disease (CAD) are
(I) to determine the likelihood of CAD , (2) to estimate
prognosis, (3) to determine functional capacity, and (4) to
determine the effects of therapy . Additional considerations
regarding any diagnostic test are whether the particular test
is needed and whether the results will influence manage-
ment, either currently or in the future.
Indications for exercise testing may be classified as fol-
lows :
Class I . Conditions for which there is general agreement
that exercise testing is justified.
Class II. Conditions for which exercise testing is fre-
quently used but in which there is a divergence of opinion
with respect to value and appropriateness .
Class III . Conditions for which there is general agree-
ment that exercise testing is of little or no value, inappro-
priate or contraindicated by risk .
General contraindications to exercise testing include un-
stable angina prior to a period of stabilization; the presence
of untreated, life-threatening arrhythmias; uncompensated
severe congestive heart failure; advanced atrioventricular
heart block; acute myocarditis; and critical aortic stenosis .
Exercise Testing in Patients With Symptoms or Signs
Suggestive of Coronary Artery Disease or With
Known Coronary Artery Disease
Summary
Class I
I . To assist in the diagnosis of coronary artery disease in
male patients with symptoms that are atypical for myo-
cardial ischemia.
2. To assess functional capacity and to aid in assessing the
prognosis of patients with known CAD.
3. To evaluate patients with symptoms consistent with re-
current, exercise-induced cardiac arrhythmias.
Class II
l. To assist in the diagnosis of CAD in women with a
history of typical or atypical angina pectoris .
2. To assist in the diagnosis of CAD in patients taking
digitalis.
3. To assist in the diagnosis of CAD in patients with com-
plete right bundle branch block.
4 . To evaluate the functional capacity and response to ther-
apy with cardiovascular drugs in patients with CAD or
heart failure.
5. To evaluate patients with variant angina.
6. To follow serially (at I year or longer intervals) patients
with known CAD .
Class III
I . To evaluate patients with simple premature ventricular
depolarizations on the resting ECG but no other evidence
of CAD.
2. To evaluate functional capacity serially in the course of
an exercise cardiac rehabilitation program.
3. To assist in the diagnosis of CAD in patients who dem-
onstrate pre-excitation (Wolff-Parkinson-White) syn-
drome or complete left bundle branch block on the resting
ECG .
Discussion
The four basic indications for obtaining an exercise stress
test in patients with known or suspected CAD are the fol-
lowing :
I. As a diagnostic test in patients with suspected CAD.
2. To assist in identifying those patients with documented
CAD who are potentially at high risk due to advanced
coronary disease and/or left ventricular dysfunction.
3. To evaluate patients after coronary artery bypass surgery
or percutaneous transluminal coronary angioplasty (see
section on "Exercise Testing After Specific Proce-
dures").
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4. To quantify a patient's functional capacity or response
to therapies , and to follow the natural course of disease
at appropriate intervals .
Diagnostic testing
Sensitivity and specificity . In certain clinical settings the
exercise test may serve as an appropriate , supplemental aid
to the history and physical examination in helping the phy-
sician decide whether a patient has ischemic heart disease .
Nonetheless, the exercise test has significant limitations as
a diagnostic tool and there is no justification for obtaining
a test on every patient who has chest pain or other abnor-
malities potentially related to ischemic heart disease . For
instance, the male patient over age 40 with a history of
typical exertional angina pectoris rarely needs an exerci se
test for diagnostic purposes . In men whose history indicates
a very high probability of CAD , an abnormal exerci se test
merely confirms the clinical assessment ( I) . On the other
hand, a negative exercise test , which occurs in at least 20%
of patients with typical exertional angina and with a normal
resting ECG , is not likely to sway the physician from his
clinical impression . In this subset of patients, however, an
exercise test may sometimes be used for the evaluation of
exercise tolerance, prognosis and severity of underlying CAD,
rather than for diagnostic purposes.
Male patient s with a history consistent with typical an-
gina pectori s have a 90% likelihood of having significant
CAD as determined by coronary arteriography (1). In con-
trast, the prevalence of CAD in women with a history of
typical angina pectoris is as low as 60 to 70% (1). A false
positive exercise ST segment response is much more fre-
quent in women than in men, and an abnormal response in
women will not greatly enhance the predictive accuracy of
the clinical diagnosis based on the history alone.
The prevalence of CAD decreases substantially as chest
pain becomes less typical for angina pectori s. In men with
atypical chest pain an abnormal exerci se test may be helpful
in arriving at a clinical diagnosis of CAD . This is especially
true if the ST segment depres sion is marked (:;::: 2.0 mm),
appears at low levels of exercise and persists for several
minutes after exercise (2). Additional abnormalities such as
negative U waves or an inappropriate blood pressure or heart
rate response further enhance the predictive value of the
test. In patients with atypical chest pain the prevalence of
CAD in men is about 2.5 times greater than in women,
while the prevalence of false positive exercise ST segment
responses with atypical pain is about 4.5 times greater in
women than in men (1). This combination of circumstances
makes the exercise ECG test in women with atypical chest
pain of very limited value.
Testing of patients with abnormal baseline electrocar-
diograms. If the patient has diagnostic ECG changes of a
previous myocardial infarction (or a previous myocardial
infarction has been clinically documented) , there is no rea-
son to perform an exercise test as a diagnostic procedure.
As noted in a following section , " Evaluating Prognosis and
Severity of Coronary Artery Disease, " however, an exercise
test in such patients may be of value for detecting remote
ischemia or additional myocardium at jeopardy. One can
also question the appropriateness of obtaining an exercise
test for the purpose of establishing a diagnosis of ischemic
heart disease in some patients with abnormal baseline
ST-T changes. In individuals with typical angina pectoris,
the presence of baseline ECG abnormalities at rest increa ses
the probability of CAD , and an exerc ise test adds little
diagnostic information. Patients with left ventricular hy-
pertrophy with repolarization abnormalities may also have
false positive ST segment changes during exercise.
The presence of left bundle branch block or other major
intraventricular conduction defects or the pre-excitation
(Wolff-Parkinson-White [WPW]) syndrome invalidates the
interpret ation of addition al ST segment changes during ex-
ercise . One exception is complete right bundle branch block
where exercise-induced abnormal ST segment depre ssion in
the lateral precordial leads (V4--{') during exercise is a reliable
indicator of myocardial ischemia.
Testing of patients receiving cardiovascular drugs. In
the presence of a normal baseline ECG , the digitalis gly-
cosides may still cause a false positive ST segment depres -
sion during and following exercise. In patients taking dig-
oxin, it is best to discontinue the drug for at least 10 to 14
days, provided there is not strong clinical contraindication .
In the absence of underl ying cardiac disease , patients who
are receiving cardiac glycosides will usually exhibit no greater
than 1.0 mm of additional ST segment depression during
or after exercise, although some have 2.0 mm depre ssion .
Cardiac abnormalities other than myocardial ischemia, such
as left ventricular hypertrophy or mitral valve prolapse, may
accentuate significantly the "digitalis ST segment effect"
during exercise (3).
The beta-blocking agents present special problems in vir-
tually every area of clinical exercise testing. In the area of
diagnostic testing, these agents often prevent the patient
from attaining the desired heart rate-blood pressure product
and also increase the prevalence of false negative ST seg-
ment responses . To abruptly withdraw a beta-blocking agent
from a patient prior to performing a diagnostic exercise test
can be hazardous in the presence of advanced CAD. Initial
diagnostic exercise testing is therefore usually performed
without discontinuing the beta-blocking agent.
Calcium antagonists and nitrates may increase the ex-
ercise duration or work load required to produce limiting
symptoms or abnormal ST segment depression , and in some
cases may prevent the appearance of the abnormal ST seg-
ment changes. If the purpose of the exercise test is to es-
tablish a diagnosis of ischemic heart disease, these drugs
should be withheld, if feasible, for at least 12 hours .
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Ventricular arrhythmias and exercise testing. In an oth-
erwise clinically healthy subject there is little or no corre-
lation between the findings of isolated or occasional pre-
mature ventricular depolarizations (PYDs) at rest in the
presence of CAD. Exercise testing of such individuals is
not appropriate for the diagnosis of CAD unless major risk
factor s are also present.
Contrary to earlier beliefs, the suppression of PYDs dur-
ing exercise testing does not exclude the presence of un-
derlying CAD . PYDs that increase in frequency and/or com-
plex ity during exercise are not necessarily diagnostic of
underlying ischemic heart disease (4). The appearance of
PYDs during exercise in a patient who is apparently free of
such arrhythmia at rest is a nondiagnostic finding (5). Mul-
tiform and consecutive PYDs are not uncommon during
maximal exercise testing although ventricular tachycardia
sustained for more than 3 to 4 beats is rare (5). The ap-
pearance of frequent PYDs during exercise in patients with
recent myocardial infarction may have clinical significance .
Evaluation offunctional capacity
In selected patients with CAD the evaluation of func-
tional capacity is a valid indication for an exercise test. The
estimate of functional capacity is useful for advice about
safe work or recreational activitie s. It may also be used to
evaluate the need for or the respon se to medical and surgical
therapies.
Evaluating prognosis and severity of coronary
artery disease
In patients who have an establi shed diagnosis of CAD ,
the exercise test is a valuable tool for assessing the functional
severity of underlying CAD and the prognosis or potential
risk for future cardiac events . The test results may also aid
in directing further diagnostic and therapeutic interventions.
Several functional, hemodynamic and electrocardiographic
parameters measured during and after exercise testing have
been shown to correlate with severity of CAD (Table I) .
Not all of these indicators, however, have been tested by
appropriate clinical trials designed to determine their prog-
nostic significance.
McNeer and colleagues (6) demonstrated that the dura-
tion of exercise, the maximal exercise heart rate and the ST
segment response discriminated between patients with low
and high survival rates, even when comparable anatomic
CAD was present. A more recent report from the Coronary
Artery Surgery Study confirmed these findings (7).
The study by McNeer and colleagues (6) did not address
the prognostic significance of other parameters that have
been correlated with significant , multiple vessel CAD, such
as downsloping ST segment depre ssion at low exercise heart
rates or work loads (8) , an inappropriate persistence of ST
segment depression after exercise (8), an abnormal ST seg-
ment depression in multiple leads (2), and an abnormal
systolic blood pressure response (9). A sustained decrease
Table 1. Exercise Test Parameters Associated With Poor
Prognosis and/or Increased Severity of CAD
Duration of symptom-limiting exercise
Failure to complete Stage II of Bruce protocol or equivalent work load
(S 6.5 METS*) with other protocols
Exercise heart rate (HR) at onset of limiting symptoms
Failure to attain HR ~ 120/min (off beta-blockers)
Time of onset, magnitude , morphology and postexercise duration of
abnormal horizontal or downsloping ST segment depression
Onset at HR < 120/min or S 6.5 METS
Magnitude ~ 2.0 mm
Postexercise duration ~ 6 min
Depression in multiple leads
Systolic BP response during or following progressive exercise
Sustained decrease of > 10 mm Hg or flat BP response (S 130 mm
Hg) during progressive exercise
Other potentially importantdeterminants
Exercise-induced ST segment elevation in leads other than aVR
Angina pectoris during exercise
Exercise-induced U wave inversion
Exercise-induced ventricular tachycardia
*Energy expenditure at rest, equivalent to an oxygen uptake of ap-
proximately 3.5 ml O2 per kilogram body weight per minute.
in systolic blood pressure following an initial, appropriate
rise during submaximal exercise is a marker of severe myo-
cardial ischemia. However, normal individuals may also
exhibit a decrease in systolic blood pressure during maximal
or near-maximal exercise. A failure of the systolic blood
pressure to rise above 130 mm Hg during symptom-limiting
exerci se testing has been correl ated with advanced left ven-
tricular dysfunction ( 10). This finding in patients after re-
covery from myocardial infarction tends to define a group
who have a higher morbidity and mortality during the sub-
sequent year. Beta-blocking agents and combined alpha-
and beta-blocking agents, such as labetalol, may also cause
a delay in the normal rise of systol ic blood pressure during
exercise.
Exercise-induced ST segment elevation appearing in leads
with abnormal Q waves reflecting a previous myocardial
infarction are usually associated with dyskinetic left ven-
tricular wall motion ( I I) . Exercise-induced ST segment el-
evation that develops in leads without abnormal Q waves
or a history of variant angina is usuall y associated with a
fixed , high-grade coronary artery steno sis. Exercise-induced
negati ve U waves have been correlated with high grade
stenosi s in either the proximal left anterior descending or
the left main coronary arteries ( 12).
Exercise-induced angina pectori s is an independent vari-
able that identifies a cohort of subjects at higher risk of
subsequent coronary events ( 13). The same is true of patients
who demonstrate chronotropic incompetence, defined as a
failure of the exercise heart rate to rise to within two standard
deviations of the expected increase (14 ,15).
It is apparent that some of the parameters listed in Table
I may be less reliable for estimating prognosis and severity
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of CAD if the patient is receiving a beta-blocking agent.
On the other hand , almost half of the patients in McNeer's
study (6) were receiving propranolol at the time of their
exerci se tests, and yet the significance of exercise duration
and ST segment response remained valid.
Testing of patients unable to perform lower
extremity exercise
Treadmill or bicycle testing is often impractical or sub-
optimal in individuals with vascular, neurologic or or-
thopedic impairment or the lower extremities. Dynamic up-
per extremity exercise testing is a useful alternative in these
patients . While some investigators found arm ergometry less
sensitive than treadmill testing in detecting CAD even when
the same peak rate-pressure product is achieved (16), others
have demonstrated no difference between tests (17). As-
sessment of tolerance to arm exercise may prove useful in
evaluating patients whose occupations require primarily up-
per extremity work .
Conclusion
In general , the exercise test should be viewed as a po-
tential adjunct to the initial clinical assessment of the patient.
Optimal use of the exercise test requires that the physician
observe the patient during the test and measure multiple
responses, of which the exerci se ECG is one. Exercise stress
testing has marked limitations for the diagnosis of CAD ,
especially in certain subsets of patients. There is no indi-
cation for applying the test to all patients being evaluated
for chest pain or other clinical manifestations potentially
related to CAD . Even when an exercise stress test is obtained
primarily for diagnostic purposes , valuable functional and
prognostic information may also be obtained. Existing data
support the concept that prognosis in patients with CAD is
not entirely dependent on the extent and severity of anatomic
lesions. Some patients who demonstrate a well preserved
functional capacity with symptom-limited exercise have a
relatively good prognosis with medical management alone,
even in the presence of advanced CAD. In such patients,
serial exercise tests at approximately I year intervals may
be useful in guiding long-term management. Marked im-
pairment of exercise tolerance , with or without other ab-
normal indicators of advanced CAD , warrants prompt con-
sideration of further diagnostic studies .
Screening of Apparently Healthy Individuals
Summary
Class I - none
Class 1/
l. To evaluate asymptomatic male patients over age 40 in
special occupations (pilots , firemen, police officers , bus
or truck drivers and railroad engineers).
2. To evaluate asymptomatic male patients over the age of
40 with two or more of the following increased risk
factors for CAD: serum cholesterol over 240 mg/dl, blood
pressure ~ 160/~90 , cigarette smoking, diabetes mel-
litus or a family history of CAD with onset under the
age of 55 years.
3. To evaluate male patient s over the age of 40 who are
sedentary and plan to enter a vigorous exercise program.
Class II/
I. To evaluate asymptomatic . apparently healthy men or
women with no risk factors for CAD.
2. To evaluate men or women with a history of chest dis-
comfort not thought to be of cardiac origin.
Discussion
Table 2 summarizes nine follow-up studies that used
maximal or near-maximal exercise testing to screen asymp-
tomatic individuals for latent CAD and one study that eval-
uated men and women with atypical chest pain. The pop-
ulations in these studies were tested and followed for the
CAD end points of angina pectori s , acute myocardial in-
farction and sudden death.
There has been controversy over whether exercise testing
provide s additional progno stic information in normal men
in the absence of conventional risk factors. In general, an-
giographic studies have confirmed the low predictive value
of an abnormal exercise test response in men or women
without conventional risk factor s or symptoms. Similar re-
sults were also found in epidemiological studies of popu-
lations with a low prevalence of CAD . Thu s, an exerci se
test is generally not appropriate in these patients.
Indications for screening apparently healthy individuals
Because it will be some time before CAD can be com-
pletely prevented, it is advisable to evaluate screening meth-
ods for diagnosing the earliest signs or symptoms of myo-
cardial ischemia in individuals at increased risk for CAD.
The use of exercise testing to induce myocardial ischemia
not detectable at rest deserve s consideration. The exercise
ECG has a sensitivity of approximately 50% and a specificity
of 90% in apparently healthy individuals (Table 2) . The
different reported predictive values are related to its use in
populations with different prevalences of coronary disease
(Appendix B). At present , it seems reasonable to screen
men over the age of 40 years who have two or more strongly
abnormal risk factors or a family history of premature car-
diovascular disease. The potential iatrogenic problems re-
sulting from screening should always be considered, and
test results should be thought of as probability statements.
not as absolutes.
It is difficult to choose a chronological age after which
exercise testing is advisable as a screening technique prior
to beginning an exercise program, since physiological age
is important. In general , if the exercise is more strenuous
than vigorous walking, most men over the age of 40 will
benefit from such testing, especially in the presence of a
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Table 2. Results of Exercise ECG Testing in Nine Prospective Studies Screening Asymptomatic Men for Latent CAD andOne Study
Evaluating Men and Women With Atypical Chest Pain Using Only ST Segment Depression as the Criterion for Abnormality
Incidence Abnormal Predictive Relative
Principal No. of ofCAD Years of Exercise Test Sensitivity Specificity Value Risk
Investigator Patients (%) Follow-Up (% ) (%) (%) (%) ( X)
Bruce (18) 22 1 2.3 5.0 11.0 60 91 14 14.0
Aronow (19) 100 9.0 5.0 16.0 67 92 46 14.0
Cumming (20) 510 4.7 3.0 13.0 58 90 25 10.0
Froelicher (2 1) 1,390 3.3 6.3 10.0 61 92 20 14.0
Allen (22) 356 9.6 5.0 23.0 4 1 79 17 2.4
Bruce (23) 2,365 2.0 6.0 11.0 30 9 1 5 3.5
McHenry (24) 916
In it ial 7. 1 12.7 2.5 14 98 39 6.0
Serial 6.7 32 95 34 6.4
Macintyre (25) 578
Men 47-57 6.9 8.0 4.0 16 97 26 4.0
Manca (26)
Men 947 5.0 5.2 18.0 67 84 18 100
Women 508 1.6 5.2 28.0 88 73 5 15.0
Average
Men only 5.4 5.4 13.0 50 90 2 1 9.0
X = -fold.
strong family history of premature coronary disease (i.e.,
family members aged less than 55 years withcoronary event),
two or more increased risk factors (serum cholesterol over
240 rng/dl, cigarette smoking, systemic hypertension 2:160/
2:90, or diabetes mellitus), or a history suggestive of myo-
cardial ischemia.
Screening of airline pilots . The character of the de-
manding work of airline pilots often makes it difficult for
them to maintain a healthy life-style. As a result, many are
overweight, deconditioned and smoke heavily. These pilots
should avail themselves of the benefits of preventive med-
icine, including periodic assessment of their physical work
capacity, their response to stress and the probability of their
having underlying coronary atherosclerosis. Similar consid-
erations apply to other individuals involved in work that
may impact upon public safety, such as truck or bus drivers,
railroad engineers, firemen and policemen.
Exercise Testing in Patients Soon After
Myocardial Infarction
Summary
Class I
1. To evaluate the prognosis and functional capacity of
patients with CAD soon after an uncomplicated myo-
cardial infarction (predischarge or early postdischarge).
Class II
I. To evaluate patients who have a Class I indication but
baseline electrocardiographic changes or coexisting med-
ical problems that limit the value of the exercise test. In
some of these patients, exercise testing may still yield
clinically valuable information (duration of exercise, blood
pressure response, productionof chest discomfort, etc. ).
2. To evaluate patients who have sustained a complicated
myocardial infarction but who have subsequently "sta-
bilized" (predischarge or early postdischarge).
Class III
I . To evaluate patients with acute ischemic heart syndrome
(unstable angina pectoris, new onset angina pectoris or
very recent acute myocardial infarction).
2. To evaluate patients with acute myocardial infarction
who have uncompensated congestive heart failure, un-
stable cardiac arrhythmias or noncardiac conditions that
severely limit their ability to exercise.
Discussion
The role of exercise testing performed within 3 weeks
of uncomplicated myocardial infarction has emerged only
during the past decade. The optimal timing for postinfarction
exercise testing represents a compromise between the risks
of precipitating recurrent infarction or death and the benefits
of therapeutic interventions arising from early evaluation of
prognosis and development of guidelines for physical ac-
tivity. The risks of early exercise testing are related to three
major factors: patient selection, timing of the test and ex-
ercisetesting methods.
Patient selection
Patient selection, which is by far the most important
single determinant of the risk of performing the test, can
be properly judged only by the supervising physician through
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a careful history and physical examination prior to testing.
Clinically significant abnormalities, especially congestive
heart failure and unstable angina pectoris, are contraindi-
cations to early testing. Other patients are medically ineli-
gible for early testing because of co-morbid conditions,
including chronic obstructive pulmonary disease, peripheral
vascular disease and orthopedic abnormalities. In other pa-
tients the interpretation of the electrocardiographic ST seg-
ment response to exercise is complicated by the existence
of bundle branch block, left ventricular hypertrophy, digi-
talis effects or resting ST segment displacement.
Timing of the test
Some physicians prefer predischarge exercise testing 10
to 14 days after uncomplicated infarction rather than testing
at 3 to 8 weeks. The risk of testing is low in properly selected
patients at either time after myocardial infarction. Some
physicians prefer to do both a predischarge test and a test
at 6 to 8 weeks before allowing the patient with uncompli-
cated myocardial infarction to return to work or usual phys-
ical activities.
Exercise test methods
A variety of treadmill test protocols are suitable for early
postinfarction testing. A convention that facilitates com-
parison of these protocols is the MET unit (see Appendix A).
The protocol selected for early postinfarction testing should
have a relatively low initial work load and small subsequent
work load increments. Most patients can comfortably tol-
erate an initial work load of two to three METS with sub-
sequent work load increments of one MET (27).
Test end points
Target heart rate. There is no evidence that a test that
is limited by attainment of an arbitrary proportion of age-
predicted heart rate is safer than one in which effort is
discontinued because of the appearance of limiting symp-
toms, clinically significant signs or significant ventricular
arrhythmias. Moreover, target heart rates are significantly
diminished by beta-blockers, which are frequently pre-
scribed for patients following myocardial infarction. The
heart rate response during symptom-limited exercise testing
may be more useful prognostically in patients not receiving
beta-blockers (28). In predischarge exercise testing, five
METS is a commonly used end point in the absence of prior
end points. In general, a symptom-limited exercise test would
identify more patients with ischemia either predischarge or
at 6 weeks after infarction. In addition, a higher level ex-
ercise test (Bruce) will frequently be positive at 6 weeks
when a low level exercise test (Naughton) is not.
Ventricular arrhythmias. It is prudent to stop an early
postinfarction exercise test because of ventricular tachycar-
dia (three or more consecutive premature ventricular de-
polarizations); however, significant ventricular arrhythmias
may be more frequent during the recovery phase than during
exercise.
Ischemic ST segment changes. It is prudent to stop an
early postinfarction exercise test because of ischemic ST
segment depression (;::: 2 mm). Exertional ST segment el-
evation is commonly noted in leads that demonstrate Q
waves, and is not necessarily an indication for discontinuing
the exercise test.
Exercise-induced hypotension. The frequent measure-
ment of systolic blood pressure during early postinfarction
exercise testing contributes importantly to the safety of the
procedure, and the blood pressure should be measured at
the end of every minute in these patients. A common con-
vention in early postinfarction exercise testing is to discon-
tinue the test when the patient develops a sustained systolic
pressure drop of 10 mm Hg or greater in comparison to the
highest value measured during a lower work load, even
though hypotension by this criterion may occur in 15 to
20% of symptom-limited postinfarction tests (29).
Patients receiving beta-blocking agents may have a higher
incidence of exertional hypotension, perhaps due in part to
the blunted exercise heart rate response and impaired left
ventricular function.
Limiting symptoms
• Angina pectoris. The incidence of exertional angina
pectoris during early postinfarction exercise testing var-
ies from 15 to 40% (30).
• Dyspnea and fatigue. These are the most frequent
symptomatic end points for early postinfarction exer-
cise testing. Together, they constitute between one-
half and two-thirds of all test end points. Voluntary
limitation by dyspnea and fatigue is a relatively repro-
ducible end point. To determine whether a patient has
attained a "clinically maximal" performance requires
clinical judgment and experience.
Clinical application of postinfarction exercise testing
The prognosis after myocardial infarction is related to
many factors, including the extent of myocardial ischemia
and of left ventricular dysfunction (31,32). The prognostic
value of exercise testing or of any diagnostic technique
therefore cannot be considered apart from the clinical char-
acteristics of the population to which it is applied. In gen-
eral, exercise testing has been restricted to clinically low
risk patients, i.e., those without congestive heart failure or
unstable angina pectoris, who comprise approximately 40
to 60% of postinfarction patients.
The prognostic value of various exercise test parameters
Exercise-induced ischemic ST segment depression. This
is the single most useful exercise test parameter for the
evaluation of prognosis of patients soon after myocardial
infarction. Patients who have ischemic ST segment depres-
sion of 1 mm or more during an exercise test performed 10
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to 21 days after an acute myocardial infarction have a risk
of subsequent cardiac events which is 3 to 20 times higher
than that of patients without this abnormality (28,29,33) .
Such patients, who comprise 30 to 40% of all patients
undergoing early exercise testing, have a risk of death or
recurrent infarction in the year after initial infarction of 5
to 15% (28,29,33). Conversely, in the 60 to 70% of patients
who do not develop exercise-induced ischemic ST segment
depression, the risk of death or recurrent infarction in the
12 months after initial infarction is as low as 2% (28,29,33).
Much of the utility of exercise testing soon after infarction
is related to its ability to identify very low risk patients,
many of whom require no additional diagnostic procedures
at that time, as well as high risk patients.
The prognostic value of exercise-induced ischemic ST
segment depression is altered by the heart rate and work
load at which the depression appears and by the clinical
characteristics of the patient population. In general, patients
with ischemic ST segment depression that appears at a low
work load have a worse prognosis for a new coronary event
or death than patients in whom a similar magnitude of isch-
emic ST segment depression occurs at a higher work load
(28). In patient populations in which clinical heart failure
and digitalis therapy are common, exercise-induced isch-
emic ST segment depression appears to be prognostically
less useful than the finding of a low peak work load of less
than four METS .
Peak work load . In general, patients who attain a high
peak work load have clinically less advanced myocardial
ischemia and left ventricular dysfunction than patients with
low peak work loads.
Exercise induced angina pectoris . Exercise-induced an-
gina pectoris is highly predictive of angina appearing during
a later phase of convalescence. In general, patients with a
low threshold for angina pectoris have a worse prognosis
for a new coronary event or death and a lower functional
capacity than patients with a high threshold (28).
Exercise induced ventricular arrhythmias. The frequency
and complexity of exercise-induced ventricular arrhythmias
are increased in early postmyocardial infarction patients with
severe underlying myocardial ischemia, left ventricular dys-
function, and regional wall motion abnormalities (4,34) .
Exercise induced ST segment elevation . This ubiquitous
and nonspecific finding has less clinical utility than other
cardiac abnormalities.
Exercise-induced hypotension. In patients with stable
chronic ischemic heart disease, exertional hypotension is a
relatively specific indicator of physiologically severe myo-
cardial ischemia that often warrants further evaluation . In
contrast, exertional hypotension in patients early after myo-
cardial infarction appears to reflect a suboptimal increase in
cardiac output arising from a transient suppression of the
peak heart rate in combination with abnormal left ventricular
function. The 10 to 20% incidence of exertional hypotension
during symptom-limited testing performed 3 weeks after
infarction decreases dramatically in the next 4 to 7 weeks
(35). Patients with a recent inferior or posterior myocardial
infarction often have well preserved left ventricular function
but a markedly attenuated heart rate and blood pressure
response to exercise, presumably caused by stimulation of
left ventricular baroreceptors or deformation receptors. It is
therefore important not to overinterpret exercise-induced
hypotension appearing during early exercise testing , since
this is a relatively common response, even in patients not
receiving beta-blockers. While exercise-induced hypoten-
sion sometimes helps to identify a subgroup of patients with
a higher incidence of severe CAD, it is relatively nonspecific
and usually does not warrant further evaluation in the ab-
sence of other, more specific test abnormalities.
For exercise testing performed 21 days or more after
infarction, symptom-limited testing appears as safe as "sub-
maximal" exercise testing. In several large studies, patients
with negative tests 2 to 3 weeks after myocardial infarction
have a 12 month mortality ofless than 2% (28,29,33). These
patients appear to have a well preserved functional capacity,
and it is probably safe for them gradually to resume most
of their customary activities .
Occupational work clearance
Symptom-limited dynamic exercise testing provides an
objective measure of cardiovascular capacity. If exercise-
induced ischemic ST segment depression or angina pectoris
are absent during symptom-limited dynamic exercise test-
ing, they are also likely to be absent during customary
activities, few of which involve an intensity of effort as
great as that encountered during testing.
Most postinfarction patients whose exercise tests are
"negative" with at least a seven MET work load 3 weeks
after uncomplicated myocardial infarction are capable of
resuming their usual occupational tasks within the next 2 to
3 weeks. In patients whose occupational activities involve
heavy physical effort or extremes of temperature, a maximal
or near-maximal exercise test performed approximately 6
to 8 weeks after infarction may be helpful in providing
clearance to resume occupational activities. Patients with
" positive" exercise tests may require further diagnostic test-
ing and consideration of medical or surgical therapeutic
interventions.
Exercise Testing After Specific Procedures
Summary
Class I
I . To evaluate patients after coronary artery revasculari-
zation by surgery or by coronary angioplasty.
Class II
I. To evaluate on a routine, yearly basis patients who re-
main asymptomatic after a revascularization procedure.
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Discussion
Coronary artery bypass grafting
Testing prior to surgery. Preoperative treadmill exercise
testing provides a baseline of exercise capacity for com-
parison following surgery . The primary indication for post-
operative exercise testing is to document that the expected
improvement has been obtained from the bypass procedure
and to serve as a baseline for later comparisons.
Postoperative testing is often indicated in patients with
one of the following circumstances: (I) suspected incom-
plete coronary revascularization (i.e., recurrent angina pec-
toris), (2) technical difficulties during or after the operation,
(3) initial difficulties in being disconnected from the extra-
corporeal support system, (4) enzymatic or electrocardio-
graphic evidence of intraoperative myocardial infarction, or
(5) other evidence of perioperative complications. Exercise
testing should be delayed for 3 months after surgery until
chest pain and leg pain from the donor vessel site has sub-
sided sufficiently to permit maximal or near-maximal ex-
ercise . Earlier testing can be performed at 3 to 6 weeks ,
but it is usually submaximal.
Even in patients with an abnormal resting ECG, much
can be learned from the exercise stress test, such as time
to maximal exercise, presence or absence of exertional an-
gina pectoris, demonstration of stable rhythm and appro-
priate blood pressure and heart rate responses. The sensi-
tivity of exercise testing for detecting two or more vessels
left ungrafted has been reported to be 96 to 100% with a
specificity of 91% (36) .
Exercise testing for late complications or progression of
disease after coronary artery bypass surgery. Repeat testing
may be indicated in patients who have recurrent angina
pectoris or a reduction in exercise capacity. The value of
routine, periodic testing in patients who remain asympto-
matic after coronary artery bypass surgery has not been
documented.
Exercise testing of patients undergoing percutaneous
transluminal coronary angioplasty (PTCA)
Pretreatment exercise testing provides a baseline for the
evaluation of improvement following PTCA. The exercise
ECG may fail to disclose ischemic abnormalities in some
patients in whom PTCA is most clearly indicated, i.e.,
symptomatic individuals with proximal stenosis in a single
vessel.
Post-treatment exercise testing can ordinarily be per-
formed with safety on the day prior to hospital discharge,
i.e ., 2 to 5 days after the procedure. The presence of ECG
abnormalities that may interfere with the interpretation of
i~ -:hemic ST segment responses does not prevent the ac-
qui.ition of other valuable data reflecting upon the adequacy
of the <oronary circulation. Evaluation of the adequacy of
the coronary circulation by 20 I Tl imaging in such patients
is often very useful.
Late follow-up testing should be performed in patients
who develop recurrence or worsening of angina pectoris or
a deterioration of exercise tolerance . Exercise testing at 3
and 6 months helps to identify the 20 to 30% of patients
who restenose in the first 6 months after the procedure.
Thereafter, annual testing may be appropriate.
Exercise Testing in Patients With Valvular
Heart Disease
Summary
Class II
I . To evaluate the functional capacity of selected patients
with valvular heart disease.
Class III
I. To evaluate patients with symptomatic critical valvular
aortic stenosis or hypertrophic obstructive cardiomyo-
pathy.
Discussion
The principal indication for performing exercise tests on
patients with valvular heart disease is to obtain objective
data on exercise capacity, which is a measure of the overall
functional capacity of the cardiovascular system. Evaluation
of rhythm, heart rate and blood pressure responses during
exercise can also contribute to better patient management,
but the value of exercise-induced ST segment abnormalities
as a sign of anatomical coronary artery disease is limited .
The functional classification of the New York Heart As-
sociation is often misleading (37,38) . A significant negative
relationship exists between exercise capacity and the se-
verity of the valvular lesion as measured by cardiac cath-
eterization and left ventriculography (37,39-41). Data ob-
tained at rest from such tests or the medical history, however,
often do not predict accurately the individual patient's re-
sponse to exercise.
Current indications for surgery for valvular heart disease
are largely based on a combination of symptoms, physical
findings , chest roentgenographic , electrocardiographic,
echocardiographic and catheterization data . Exercise test
data may also be helpful in making decisions regarding
catheterization and may provide a basis for advice about
occupational and recreational physical activity . In selected
patients serial exercise studies at I to 3 year intervals can
be used to document progression of the disease and the effect
of any therapeutic intervention . In general, exercise testing
performed to evaluate the functional capacity of patients
with valvular heart disease should be symptom-limited.
Mitral valve disease
Most patients with hemodynamically significant mitral
stenosis have decreased exercise capacity (39-41). Relative
tachycardia is an ineffective compensatory mechanism be-
cause the shorter period of diastolic filling further decreases
left ventricular filling, particularly in patients with atrial
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fibrillation; therefore, control of the ventricular response by
medication is essential (42,43). Exercise testing can provide
an objective measure of functional capacity, particularly in
patients who deny or minimize symptoms.
Patients with chronic mitral regurgitation often remain
asymptomatic with well preserved exercise tolerance until
the regurgitant volume becomes very large and is associated
with high right-sided pressures. Abnormal ST responses to
exercise may be found in patients with and without under-
lying CAD. Exercise testing is useful in establishing the
degree of functional limitation in many patients with mitral
regurgitation.
Patients with mitral valve prolapse form a heterogeneous
subgroup. In the largest group of patients with primary or
idiopathic prolapse, there is little evidence for exercise-
induced myocardial ischemia despite the common history
of chest pain and the common occurrence of exercise-in-
duced ST segment abnormalities. The mechanism for ST
segment abnormalities is unknown, but autonomic dys-
function may be an important factor (44).Exercise testing
is not usually appropriate for patients with mitral valve
prolapse unless there is evidence of marked mitral regur-
gitation or exertionally induced cardiac arrhythmias. Less
frequently, mitral valve prolapse is secondary to CAD with
papillary muscle dysfunction.
Aortic valve disease
Clinical evidence for critical aortic stenosis is generally
regarded as a contraindication for exercise testing. Exercise-
induced syncope, at times apparently caused by a depressor
response with vasodilatation and bradycardia (45,46), is a
feared complication. On the other hand, careful testing can
be performed safely in patients with mild to moderate lesions
(47). Angina and abnormal ST segment responses are likely
to reflect myocardial ischemia, but these abnormalities pro-
vide little information about the presence or absence of
significant CAD when left ventricular hypertrophy is present
(48).
Limitations also apply to the evaluation of ST segment
changes in patients with aortic regurgitation. Exercise ca-
pacity is often well maintained in the presence of significant
regurgitation and left ventricular hypertrophy because of the
increased heart rate, decrease in diastolic time and peripheral
artery dilatation during exercise, despite severe left ven-
tricular dysfunction in many patients. In some patients, how-
ever, a decrease in functional capacity may serve as an
additional guide in timing cardiac surgery.
Exercise Testing in the Management of Patients
With Hypertension or Cardiac Pacemakers
Summary
Class II
I. To evaluate the blood pressure response of patients being
treated for systemic arterial hypertension who wish to
engage in vigorous dynamic or static exercise.
Class III
1. To evaluate patients with severe, uncontrolled systemic
hypertension.
2. To evaluate the blood pressure response to exercise in
patients treated for hypertension who are not engaging
in vigorous exercise.
3. To evaluate pacemaker function in patients with cardiac
pacemakers.
Discussion
Exercise testing in patients with hypertension
Many investigators have used exercise testing for the
diagnosis, categorization and treatment of patients with sys-
temic hypertension (49-52). Exercise testing should not be
performed in patients with uncontrolled severe hyperten-
sion. Exercise testing may be useful in helping to identify
individuals with labile high blood pressure more likely to
develop persistent hypertension, but it is not indicated in
the routine management of patients with hypertension. It
may be useful in patients who engage in vigorous dynamic
or static exercise.
Exercise testing in patients with cardiac pacemakers
In general, exercise testing is not appropriate in most
patients with cardiac pacemakers. In a few selected patients,
however, such testing may occasionally help in the evalu-
ation of overall cardiovascular performance during exercise.
Exercise Testing in Children
Summary
Class I
1. To evaluate the functional capacity of selected patients
with congenital heart disease.
Class II
1. To evaluate the functional capacity of patients with val-
vular or congenital heart disease.
Discussion
In general, exercise testing in children is a safe (53-55)
and useful noninvasive test for the management of selected
children with suspected or asymptomatic cardiovascular
disease.
Indications for exercise testing in children include (1)
quantitation of the patient's exercise tolerance; (2) detection
of electrophysiologic, hemodynamic or symptomatic re-
sponses that might indicate increased risk from underlying
heart disease; (3) periodic evaluation of therapy or of the
post surgical status; (4) detection of evidence of myocardial
ischemia; and (5) detection of exercise-induced arrhythmia.
Exercise testing has proven to be particularly useful in the
evaluation of patients with congenital aortic stenosis, coarc-
tation of the aorta, tetralogy of Fallot, arrhythmias, chest
pain syndromes and adolescent hypertension (54). In se-
lected patients, it may also help provide guidelines for par-
ticipation in athletic activities (56).
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Appendix A
The exercise test
The ECG, heart rate and blood pressure reponse should
be carefully monitored and recorded by a physician during
each stage of exercise (57) and at time of onset of ST
segment abnormalities or chest pain. The physician should
also observe for transient rhythm disturbances and other
ECG manifestations of myocardial ischemia , such as intra-
ventricular conduction disturbances and negative U waves.
End points for graded exercise testing
Many exercise laboratories employ submaximal tests, in
which target heart rate end points correspond to 85 to 90%
of the predicted maximal heart rate observed in normal
subjects . The test is terminated short of the target heart rate
if limiting symptoms such as increasing angina or severe
dyspnea occur. The poor relationship between the maximal
heart rate and age and the large scatter around the predicted
regression line must be understood. Symptom-limited test-
ing is preferable to submaximal testing when the test is used
to evaluate a patient's functional capacity . The target heart
rate approach has major limitations in patients receiving
,B-adrenergic blocking agents and in those with heart rate
impairment or excess heart rate response.
Indications for terminating an exercise test, irrespective
of the patient's symptomatic status or exercise heart rate,
include a progressive and reproducible decrease in systolic
blood pressure , a decreasing heart rate or the appearance of
three consecutive PVDs. Excessive horizontal or down-
sloping ST segment depression (~ 2.0 mm) is often an
indication for terminating a test.
Optimal lead systems
With few exceptions, a clinical exercise laboratory should
monitor and record a minimum of three ECG leads corre-
sponding to orthogonal X,Y and Z leads. Probably the most
popular lead combination in use today consists of leads aVF,
V2 and V5 • The use of multiple (3 to 12) leads increases
the sensitivity of the exercise ECG for detecting abnormal
ST segment depression by 8 to 20% when compared with
a single lateral precordial lead; a 12 lead system is preferable
(58). The occurrence of abnormal ST segment depression
in multiple leads may also be a useful marker of the severity
of underlying CAD (2).
Causes offalse positive ECG responses to exercise
Individuals with labile ST-T wave changes under various
conditions have an increased incidence of false positive ST
segment changes with exercise (59) . These changes may be
unmasked by recording the ECG after 20 to 30 seconds of
voluntary hyperventilation in the standing position . If hy-
perventilation produces ST segment depression (~ 0.5 mm)
or a reversal of polarity of the T wave, then abnormal ST
segment depression during exercise must be interpreted with
caution.
In individuals with left ventricular hypertrophy (hyper-
tension, valvular heart disease or other causes), exercise-
induced ST segment depression may result from hypertro-
phy alone, even when baseline ST-T segments are nor-
mal (3).
The incidence of false positive ST segment responses to
exercise is higher in women than in men; the explanation
for this phenomenon remains unclear. Patients with mitral
valve prolapse also have a higher incidence of false positive
ST segment responses , perhaps because they also have a
predilection toward labile ST-T wave changes .
Baseline ST depression or T wave inversion, digitalis
therapy , hypokalemia, anemia and hypoxemia increase the
rate of false positive ST segment responses to exercise .
Appendix B
Definitions of terms commonly used in exercise testing
Sensitivity and specificity
The classic ECG response to ischemia on the exercise
test is ST segment depression . Although many other exercise
test variables are also correlated with coronary arterio-
graphic findings, the ST segment response is still the ac-
cepted standard . The most commonly used definition for a
positive ECG exercise test is ~ I mm of horizontal or
downward ST segment depression or elevation for at least
Table 3. Statistical Evaluation of Exercise Test Results
TP
TN
FN (false negative ) = negative exercise ECG and positive angiogram; FP (false positive) positive
exercise ECG and negative angiogram; TN (true negative ) = negative exercise ECG and negative angiogram;
TP (true positive) = positive exercise ECG and positive angiogram.
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0.08 second after the end of the QRS complex, compared
with the rest value (TP or PQ segment). When the rest ST
segments are abnormal, an additional I to 2 mm of ST
segment depression or elevation is accepted as a positive
response. The specificity, however , may be considerably
less than if the ECG at rest is normal. Correlations between
an abnormal (positive) test and the presence of coronary
disease, determined either angiographically or by clinical
follow-up, are best expressed by the epidemiologic terms
" sensitivity , " "specificity" and "predictive value, " which
are defined in Table 3.
In general, sensitivity is an expression (in percent) of the
ability of a test to identify individuals who have a given
disorder, while specificity reflects the test's ability to iden-
tify individuals who do not have the disorder (Table 3).
Thus, sensitivity reflects how reliably a positive test iden-
tifies disease, and specificity reflects how reliably a negative
test identifies the absence of disease .
The most important determinant of sensitivity or speci-
ficity is the criterion or discriminant value used to define
an abnormal test result. Thus , as the criteria required for a
positive test result increase , the sensitivity decreases and
the specificity increases. For example, if the amount of
coronary stenosis used to define disease was placed at 70%
diameter narrowing (91 % decrease in cross-sectional area)
rather than 50% diameter narrowing (75% decrease in cross-
sectional area), the sensitivity of exercise testing decreases
while the specificity increases . Conversely , when the criteria
are made less stringent, the sensitivity increases but the
specificity decreases . Another important determinant of sen-
sitivity and specificity is the number of leads used to monitor
the exercise electrocardiographic response. As the number
of leads increases from I to 12, the sensitivity increases
from 56 to 76%, while the specificity decreases from 94 to
82% (58).
The so-called likelihood ratio expresses the relative chance
of observing a given test outcome among diseased and non-
diseased patients. In the case of an abnormal test result, the
likelihood ratio can be defined by the following equation:
sensitivity/( I-specificity) .
Predictive value and Bayes's theorem
The predictive value of a test is the likelihood that disease
is present or absent depending on whether the test is positive
or negative, respectively (Table 3). The sensitivity and spec-
ificity and corresponding likelihood ratios will determine
how accurate certain test results will be (i.e., the test's
predictive value).
A major determinant of the predictive accuracy of a test
result is the prevalence of disease in the population under
study, i.e ., the likelihood of having disease before the test
is undertaken or the pretest probability. This concept is
referred to as Bayes's theorem, a statistical law of condi-
tional probability that states that the likelihood of disease
after a diagnostic test (the post-test risk) cannot be estimated
from the test result alone but requires knowledge of the
prevalence of disease (pretest risk) for the individual pop-
ulation group in question (60-62). Thus, the predictive ac-
curacy of any test outcome that is less than a perfect di-
agnostic test (i.e ., less than 100% specific) is influenced by
the pretest likelihood of disease and by the criteria used to
define a test result.
Definition of MET
A MET unit is the energy expenditure at rest, equivalent
to an oxygen uptake of approximately 3.5 ml O2 per kilo-
gram body weight per minute. Exercise tests may be stan-
dardized in terms of the oxygen consumption (ml 02/kg/min)
associated with a specific work load. Exercise protocols
have been developed so that each work load approximates
a multiple of the oxygen consumption at rest, i.e., two or
three times the oxygen consumption of rest in mllkg/min,
or 2 METS, 3 METS etc . Patients limited by symptoms
usually have a work load capacity of about 6 METS or less,
while asymptomatic patients may have performance capac-
ities ranging from 7 to 10 METS or more. Regularly active
healthy men may have capacities of 12 to 15 METS and
endurance athletes 16 to 20 METS.
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